High Cholesterol (Hyperlipidemia) Clinical Trials

A listing of High Cholesterol (Hyperlipidemia) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 71 clinical trials
featured
Do you have high cholesterol? We may have a medical research study for you

Do you have high cholesterol? We may have a medical research study for you

  • 146 views
  • 23 Nov, 2020
  • 1 location
featured
High Cholesterol?

High Cholesterol?

  • 636 views
  • 25 Mar, 2021
  • 1 location
The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

JS002 is a recombinant humanized anti-PCSK9 monoclonal antibody. This is a randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy, as well as immunogenicity of JS002 treated repeatedly in patients with hyperlipidemia when combined with statin therapy. In this study, two dose group (150 mg, 300 mg) were set …

  • 0 views
  • 19 Mar, 2021
  • 5 locations
Safety and Efficacy of IBI306 in Chinese Subjects With Non-familiar Hypercholesterolemia

IBI306 is a fully human monoclonal antibody that binds proprotein convertase substilisin/kexin type 9 (PCSK-9), preventing its interaction with the low-density lipoprotein cholesterol receptor (LDL-R) and thereby restoring LDL-R recycling and low-density lipoprotein cholesterol(LDL-C) uptake. This study is being done to investigate the effects of IBI306 in Chinese people with …

monoclonal antibody
hypercholesterolemia
ezetimibe
LDL Cholesterol
cholesterol measurement
  • 0 views
  • 27 Jan, 2021
  • 1 location
Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

A multicenter study to evaluate safety and efficacy of inclisiran in Asian patients with ASCVD or ASCVD high risk and elevated LDL-C

stroke
low density lipoprotein
atherosclerosis
ezetimibe
diabetes
  • 0 views
  • 18 Sep, 2021
  • 29 locations
Study to Investigate Safety Tolerability PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

This study will investigate the safety and tolerability of SLN360 in patients with elevated Lp(a).

cardiovascular disease
body mass index
  • 0 views
  • 02 Jul, 2021
  • 7 locations
TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients

To assess the efficacy and safety of orally administered Epeleuton capsules versus placebo, in the treatment of adult patients with hypertriglyceridemia and type 2 diabetes

metabolic syndrome
fasting
hemoglobin a1c
type 2 diabetes mellitus
diabetes
  • 0 views
  • 17 Sep, 2021
  • 27 locations
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications

The study plans to learn if sending different text messages, serving as reminders or encouragement, may help patients take their medication more often if they have had trouble keeping up with their medicines.

  • 0 views
  • 26 Jan, 2021
  • 2 locations
Onco-primary Care Networking to Support TEAM-based Care

The proposed ONE TEAM Study is an 18-month, cluster randomized controlled trial. This study will use a sequential multiple assignment randomized trial (SMART) design with a second randomization for the intervention group using a dynamic treatment regimen approach. The investigators propose to randomize 800 adults with newly-diagnosed selected cancers treated …

lung cancer
hypercholesterolemia
cancer care
hypertension
chronic disease
  • 0 views
  • 15 Jun, 2021
  • 1 location
A Study to Assess the Safety Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

AZD8233 is a PCSK9-targeted ASO for the reduction of circulating levels of LDL-C. This study aims to evaluate safety, efficacy and tolerability of AZD8233.

pcsk9
ezetimibe
fasting
hmg-coa reductase inhibitors
  • 10 views
  • 20 Sep, 2021
  • 76 locations